Association of insurance type with unmet need for menopause care in Oregon

Abstract

Objective To determine unmet need for menopause care in Oregon and evaluate if insurance type is associated with receipt of care. Methods We conducted a cross-sectional survey of patients using an Oregon Listserv. Our primary outcome was use of medication for the treatment of moderate or severe symptoms of menopause. We used the Menopause Rating Scale to evaluate respondents' symptoms: 0–4 none or little symptoms; 5–8 mild symptoms; 9–16 moderate symptoms; and 17+ severe symptoms. We abstracted demographic and clinical information including age, rurality, race, ethnicity, primary language, and insurance type. We used a regression model to determine the association between public insurance and treatment for moderate to severe menopause symptoms. We examined reasons for nonuse of therapy. Results Our sample included 845 perimenopausal or postmenopausal individuals who were predominantly White (93.0%), aged 45–49 (32.8%) or 50–54 years (39.1%), and privately insured (81.3%). Overall, 62.4% of individuals with moderate and severe symptoms of menopause were not receiving any therapy. After adjustment for age and rurality, public insurance was associated with an average of 47% increased odds of nontreatment for moderate or severe menopause symptoms (adjusted odds ratio: 1.47, 95% CI: 0.99–2.19). The most common reasons for nontreatment in both groups were “therapy was not recommended by a provider” (43%) and worries about safety or side effects (40%). Conclusions Even in well-insured persons, the majority of people with moderate and severe symptoms of menopause are not receiving treatment. People who are publicly insured are more likely to go untreated than privately insured individuals.